Study of left ventricular functions in asymptomatic obese individuals with 2D echo cardiography

 

REFERENCES

1. Coronary artery disease. National Lung, Heart, and Blood Institute.
2.  http://www.nhlbi.nih.gov/health/dci/Diseases/Cad/CAD_WhatIs.html
3. World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster (2004). The global burden of disease 2004 update. Geneva: WHO. ISBN 92-4-156371-0.
4. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111–9.
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alfa in human obesity and insulin resistance. J Clin Invest 1995;95:2409–15.
6. Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996;93:106–10.
7. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307–12.
8. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462–4.
9. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605– 619Americans. J Am Med Assoc. 1978;240:1607–1610.
10. Troy M. Labounty, Millie J. Gomez, Stephan Achenbach and et al, Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13 874 patients European Heart Journal - Cardiovascular Imaging Advance Access published August 24, 2012.
11. Mechanisms of obesity-induced hypertension, Vasilios Kotsis, Stella Stabouli, Sofia Papakatsika,, Zoe Rizos3 and Gianfranco Parati,Hypertension Research (2010) 33:386–393.
12. Klop B, Elte JW, Cabezas MC,Dyslipidemia in obesity: mechanisms and potential targets,Nutrients. 2013 Apr 12;5(4):1218-40.
13. Paul Poirier, Thomas D. Giles, George A. Bray, Yuling Hong, Judith S. Stern, F. Xavier Pi-Sunyer and Robert H. Eckel ,Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss, Arterioscler Thromb Vasc Biol. 2006;26:968-97.
14. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260.
15. G de Simone, R B Devereux, M J Roman, M HAlderman and J H Laragh, Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults Hypertension, 1994;23:600-606.
16. M. Fischer, A. Baessler, H.W. Hense, and et al Prevalence of left ventricular diastolic dysfunction in the community Results from a Doppler echocardiographic-based survey of a population sample European Heart Journal (2003) 24:320–328.